Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 29;130(9):1365-1381.
doi: 10.1161/CIRCRESAHA.122.320084. Epub 2022 Apr 28.

New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis

Affiliations
Review

New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis

Micheala A Aldred et al. Circ Res. .

Abstract

Pulmonary arterial hypertension (PAH) is a complex multifactorial disease with poor prognosis characterized by functional and structural alterations of the pulmonary circulation causing marked increase in pulmonary vascular resistance, ultimately leading to right heart failure and death. Mutations in the gene encoding BMPRII-a receptor for the TGF-β (transforming growth factor-beta) superfamily-account for over 70% of families with PAH and ≈20% of sporadic cases. In recent years, however, less common or rare mutations in other genes have been identified. This review will consider how these newly discovered PAH genes could help to provide a better understanding of the molecular and cellular bases of the maintenance of the pulmonary vascular integrity, as well as their role in the PAH pathogenesis underlying occlusion of arterioles in the lung. We will also discuss how insights into the genetic contributions of these new PAH-related genes may open up new therapeutic targets for this, currently incurable, cardiopulmonary disorder.

Keywords: arterioles; hypertension, pulmonary; lung; mutation; prognosis.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Genetic mutations associated with familial pulmonary arterial hypertension (PAH):
(adapted from ).
Figure 2:
Figure 2:. The BMP signalling pathway.
BMP ligands can form homo- or heterodimers which signal through a tetrameric set of receptors, comprising two type I and two type II receptors. Binding of BMP dimers to the receptors triggers a phosphorylation cascade that result in phosphorylation of Smad 1/5/8 and players of various non-SMAD pathways to initiate SMAD and non-SMAD signaling cascades. The non-SMAD pathways include signaling by mitogen-activated proteins kinases (MAPKs p38, ERK, and JNK), PI3K/AKT, and small Rho-like GTPases. Phosphorylated Smads are able to form complexes with Smad4 and translocate to the nucleus. (Illustration credit: Ben Smith)
Figure 3:
Figure 3:. PAH physiopathology: a puzzle with many missing pieces.
(Illustration credit: Ben Smith)

References

    1. Humbert M, Guignabert C, Bonnet S, Dorfmuller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, Rabinovitch M. Pathology and pathobiology of pulmonary hypertension: State of the art and research perspectives. Eur Respir J. 2019;53 - PMC - PubMed
    1. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53 - PMC - PubMed
    1. Evans JD, Girerd B, Montani D, Wang XJ, Galie N, Austin ED, Elliott G, Asano K, Grunig E, Yan Y, Jing ZC, Manes A, Palazzini M, Wheeler LA, Nakayama I, Satoh T, Eichstaedt C, Hinderhofer K, Wolf M, Rosenzweig EB, Chung WK, Soubrier F, Simonneau G, Sitbon O, Graf S, Kaptoge S, Di Angelantonio E, Humbert M, Morrell NW. Bmpr2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis. Lancet Respir Med. 2016;4:129–137 - PMC - PubMed
    1. Morrell NW, Aldred MA, Chung WK, Elliott CG, Nichols WC, Soubrier F, Trembath RC, Loyd JE. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 2019;53 - PMC - PubMed
    1. Larkin EK, Newman JH, Austin ED, Hemnes AR, Wheeler L, Robbins IM, West JD, Phillips JA 3rd, Hamid R, Loyd JE. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:892–896 - PMC - PubMed

Publication types

Substances